The market

Every tracked compound, and what the record says about it.

How many human studies exist for each compound, how far they got, and whether any regulator has approved a product built on it. Counts come from ClinicalTrials.gov and Drugs@FDA and are re-checked against the intervention each trial actually registered. Nothing here is a recommendation to take anything.

How this data is collected →

What the public record holds

Compounds checked

68 of 68

Looked up against ClinicalTrials.gov and Drugs@FDA on Aug 2, 2026

With an approved product

19

49 have no FDA-approved product containing them

No human study at all

25

Not one registered trial on ClinicalTrials.gov names them as an intervention. See which · Why clinic prices differ

Registered studies counted

3,186

Across every tracked compound, verified against the intervention named in each trial

Every compound tracked here, ordered by monthly readership of its English Wikipedia article. Readership is not search volume, sales or demand.

Every tracked compound, and what the record says about it.Study counts include only trials whose registered intervention names the compound — the registry search is fuzzy, so every match is re-checked. FDA status means an approved product exists whose active ingredient is that compound. Neither is a statement about whether anything works or is safe.Every column is here — slide the table sideways to read the rest, or open it on a wider screen.
#WatchlistCompoundCategoryFDA statusapproved product existsHuman studiesregistered on ClinicalTrials.govEvidencehow much is knownReadershipWikipedia readers / month
7NAD+NADNote: 260 loose registry matches, 71 confirmedLongevity & cellularResearch onlyno FDA approval71 studiesto phase 4B · Moderate — Reached phase 3 or 4, not approved19,297readers / month
8GlutathioneGSHNote: 267 loose registry matches, 72 confirmedLongevity & cellularResearch onlyno FDA approval72 studiesto phase 4B · Moderate — Reached phase 3 or 4, not approved14,776readers / month
19EpithalonEPITLongevity & cellularResearch onlyno FDA approval0 studiesno phase listedX · None — No registered human study5,080readers / month
35SS-31SS31Longevity & cellularApprovedFORZINITY21 studiesto phase 4A · Strong — An approved product exists1,883readers / month
40FOXO4-DRIFOXO4Longevity & cellularResearch onlyno FDA approval0 studiesno phase listedX · None — No registered human study1,079readers / month
43HumaninHUMNNote: 3 loose registry matches, 0 confirmedLongevity & cellularResearch onlyno FDA approval0 studiesno phase listedX · None — No registered human study671readers / month